CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Tumor-infiltrating cytotoxic T lymphocytes (TILs), including CD8 TILs, have been associated with favorable clinical outcomes in multiple tumor types. Tumor-infiltrating CD8 T cells and major histocompatibility complex (MHC) class I expression in urothelial carcinoma (UC) have not been previously reported. Most immune responses are mediated by local cytotoxic lymphocytes (CD8 T cells), which can eradicate tumor cells by recognizing tumor-associated antigens presented by MHC class I molecules. Here we analyzed the presence of intratumoral CD8 T cells, the expression of MHC class I antigen, and the expression of the NY-ESO-1 tumor antigen in UC samples and correlated our findings with clinical outcome. Immunohistochemical staining for intratumoral CD8 T cells in tissue samples from 69 patients with UC showed that patients with advanced UC (pT2, pT3, or pT4) and higher numbers of CD8 TILs within the tumor (> or =8) had better disease-free survival (P < 0.001) and overall survival (P = 0.018) than did patients with similar-staged UC and fewer intratumoral CD8 TILs. We conclude that the extent of intratumoral CD8 TILs is an important prognostic indicator in advanced UC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It was later shown that TILs, including CD8 T cells, correlated with clinical outcomes in multiple tumor types, including ovarian cancer and bladder cancer (146, 147).”
From The Next Decade of Immune Checkpoint Therapy (2021) · cites this paper as [147]
Citations
Cites
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma
van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A., & Boon, T. (1991) · Science · doi:10.1126/science.1840703 · Cited by 3,545
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
Zhang, L., Conejo-Garcia, J. R., Katsaros, D., Gimotty, P. A., Massobrio, M., Regnani, G., Makrigiannakis, A., Gray, H., Schlienger, K., Liebman, M. N., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020177 · Cited by 3,397
Sato, E., Olson, S. H., Ahn, J., Bundy, B., Nishikawa, H., Qian, F., Jungbluth, A. A., Frosina, D., Gnjatic, S., Ambrosone, C., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509182102 · Cited by 2,372
Self-citationCancer/testis antigens, gametogenesis and cancer
Simpson, A. J. G., Caballero, O. L., Jungbluth, A., Chen, Y.-T., & Old, L. J. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1669 · Cited by 1,582
Self-citationCD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer.
Naito, Y., Saito, K., Shiiba, K., Ohuchi, A., Saigenji, K., Nagura, H., & Ohtani, H. (1998) · PubMed · Cited by 1,193
Human neoplasms elicit multiple specific immune responses in the autologous host.
Sahin, U., Türeci, O., Schmitt, H., Cochlovius, B., Johannes, T., Schmits, R., Stenner, F., Luo, G., Schobert, I., & Pfreundschuh, M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11810 · Cited by 1,078
The cancer/testis genes: review, standardization, and commentary.
Scanlan, M. J., Simpson, A. J. G., & Old, L. J. (2004) · PubMed · Cited by 667
Self-citationNakano, O., Sato, M., Naito, Y., Suzuki, K., Orikasa, S., Aizawa, M., Suzuki, Y., Shintaku, I., Nagura, H., & Ohtani, H. (2001) · PubMed · Cited by 639
Tumor antigens recognized by T cells
Boon, T., Coulie, P. G., & Van den Eynde, B. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)80020-5 · Cited by 537
Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas.
Schumacher, K., Haensch, W., Röefzaad, C., & Schlag, P. M. (2001) · PubMed · Cited by 503
BCG immunotherapy of bladder cancer: 20 years on
Alexandroff, A. B., Jackson, A. M., O'Donnell, M. A., & James, K. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07422-4 · Cited by 471
Davis, I. D., Chen, W., Jackson, H., Parente, P., Shackleton, M., Hopkins, W., Chen, Q., Dimopoulos, N., Luke, T., Murphy, R., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403572101 · Cited by 440
Self-citationBoon, T., & Old, L. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80049-0 · Cited by 283
Self-citationStam, N. J., Vroom, T. M., Peters, P. J., Pastoors, E. B., & Ploegh, H. L. (1990) · International Immunology · doi:10.1093/intimm/2.2.113 · Cited by 250
Chiba, T., Ohtani, H., Mizoi, T., Naito, Y., Sato, E., Nagura, H., Ohuchi, A., Ohuchi, K., Shiiba, K., Kurokawa, Y., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602201 · Cited by 201
Self-citationSadanaga, N., Nagashima, H., Mashino, K., Tahara, K., Yamaguchi, H., Ohta, M., Fujie, T., Tanaka, F., Inoue, H., Takesako, K., et al. (2001) · PubMed · Cited by 193
Interferon-γ and Cancer Immunoediting
Dunn, G. P., Ikeda, H., Bruce, A. T., Koebel, C. M., Uppaluri, R., Bui, J. D., Chan, R., Diamond, M. S., White, J. M., Sheehan, K. C. F., et al. (2005) · Immunologic Research · doi:10.1385/ir:32:1-3:231 · Cited by 156
Identification of cancer/testis genes by database mining and mRNA expression analysis
Scanlan, M. J., Gordon, C., Williamson, B., Lee, S., Chen, Y., Stockert, E., Jungbluth, A. A., Ritter, G., Jäger, D., Jäger, E., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.10276 · Cited by 138
Self-citationNishiyama, T., Tachibana, M., Horiguchi, Y., Nakamura, K., Ikeda, Y., Takesako, K., & Murai, M. (2001) · PubMed · Cited by 110
Cancer-Testis Antigens: Expression and Correlation with Survival in Human Urothelial Carcinoma
Sharma, P., Shen, Y., Wen, S., Bajorin, D. F., Reuter, V. E., Old, L. J., & Jungbluth, A. A. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0527 · Cited by 92
Self-citationCancer-testis antigens: targets for cancer immunotherapy.
Chen, Y., & Old, L. J. (1999) · PubMed · Cited by 75
Self-citationSharma, P., Gnjatic, S., Jungbluth, A. A., Williamson, B., Herr, H. W., Stockert, E., Dalbagni, G. M., Donat, S. M., Reuter, V. E., Santiago, D., et al. (2003) · PubMed · Cited by 74
Self-citationGnjatic, S., Atanackovic, D., Matsuo, M., Jäger, E., Lee, S. Y., Valmori, D., Chen, Y., Ritter, G., Knuth, A. K., & Old, L. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.3.1191 · Cited by 61
Self-citationSharma, M., Shinde, R., McGaha, T., Huang, L., Holmgaard, R., Wolchok, J., Mautino, M., Celis, E., Sharpe, A., Francisco, L., et al. (2015) · Journal for ImmunoTherapy of Cancer · doi:10.1186/2051-1426-3-s2-o19 · Cited by 56
Méndez, R., Serrano, A., Jäger, E., Maleno, I., Ruiz‐Cabello, F., Knuth, A. K., & Garrido, F. (2001) · Tissue Antigens · doi:10.1034/j.1399-0039.2001.057006508.x · Cited by 35
Ponticiello, A., Perna, F., Maione, S., Stradolini, M., Testa, G., Terrazzano, G., Ruggiero, G., Malerba, M., & Sanduzzi, A. (2004) · Respiratory Medicine · doi:10.1016/j.rmed.2003.12.003 · Cited by 33
Simons, M. A., Hayward, A. R., Gathings, W. E., Lawton, A. R., Young‐Cooper, G. O., Cooper, M. D., & Mage, R. G. (1979) · European Journal of Immunology · doi:10.1002/eji.1830091110 · Cited by 23
Peptide Vaccination in Clinical Oncology
Jäger, E., Jäger, D., & Knuth, A. K. (2000) · Oncology Research and Treatment · doi:10.1159/000027202 · Cited by 17
Research works printed but not linked: 8
- K Schumacher, W Haensch, C Roefzaad, PM Schlag Cancer Res 61, 3932–3936 (2001).
- Y Naito, K Saito, K Shiiba, A Ohuchi, K Saigenji, H Nagura, H Ohtani Cancer Res 58, 3491–3494 (1998).
- O Nakano, M Sato, Y Naito, K Suzuki, S Orikasa, M Aizawa, Y Suzuki, I Shintaku, H Nagura, H Ohtani Cancer Res 61, 5132–5136 (2001).
- YT Chen, LJ Old Cancer J Sci Am 5, 16–17 (1999).
- MJ Scanlan, AJ Simpson, LJ Old Cancer Immun 4, 1 (2004).
- E Jager, D Jager, A Knuth Onkologie 23, 410–415 (2000).
- T Nishiyama, M Tachibana, Y Horiguchi, K Nakamura, Y Ideda, K Takesako, M Murai Clin Cancer Res 7, 23–31 (2001).
- N Sadanaga, H Nagashima, K Mashino, K Tahara, H Yamaguchi, M Ohta, T Fujie, F Tanaka, H Inoue, K Takesako, T Akiyoshi, M Mori Clin Cancer Res 7, 2277–2784 (2001).
Cited by
The immune contexture in human tumours: impact on clinical outcome
Fridman, W. H., Pagès, F., Sautès-Fridman, C., & Galon, J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3245 · Cited by 4,981
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
Sade-Feldman, M., Yizhak, K., Bjorgaard, S. L., Ray, J. P., de Boer, C. G., Jenkins, R. W., Lieb, D. J., Chen, J. H., Frederick, D. T., Barzily-Rokni, M., et al. (2018) · Cell · doi:10.1016/j.cell.2018.10.038 · Cited by 2,053
Immune infiltration in human tumors: a prognostic factor that should not be ignored
Pagès, F., Galon, J., Dieu-Nosjean, M.-C., Tartour, E., Sautès-Fridman, C., & Fridman, W.-H. (2010) · Oncogene · doi:10.1038/onc.2009.416 · Cited by 1,087
Treatment of muscle‐invasive and advanced bladder cancer in 2020
Patel, V. G., Oh, W. K., & Galsky, M. D. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21631 · Cited by 1,014
Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation
Dhatchinamoorthy, K., Colbert, J. D., & Rock, K. L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.636568 · Cited by 1,077
Metadata
- Authors
- Sharma, P., Shen, Y., Wen, S., Yamada, S., Jungbluth, A. A., Gnjatic, S., Bajorin, D. F., Reuter, V. E., Herr, H., Old, L. J., & Sato, E.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Tokyo Medical University (JP)
- Ludwig Cancer Research (BE)
- Memorial Sloan Kettering Cancer Center (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2007-03-06
- Volume
- 104
- Issue
- 10
- Pages
- 3967-3972
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1820692
- OpenAlex
- W2093773243
- Cited by
- 526
- References
- 29
- Citations by year
- 2026: 13 · 2025: 11 · 2024: 25 · 2023: 38 · 2022: 51 · 2021: 54 · 2020: 40 · 2019: 40 · 2018: 32 · 2017: 35 · 2016: 34 · 2015: 32 · 2014: 25 · 2013: 16 · 2012: 15
- FWCI
- 13.64
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Bladder and Urothelial Cancer Treatments
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- CD8+ T cells, tumor-infiltrating lymphocytes, muscle-invasive urothelial carcinoma, prognostic factors, MHC class I expression, NY-ESO-1, disease-free survival, overall survival, tumor immune microenvironment, tumor-associated antigens
- MeSH terms
- Antigens, Neoplasm, Urinary Bladder Neoplasms, Carcinoma, Female, Genes, MHC Class I, Humans, Immunohistochemistry, Male, Muscles, Prognosis, Lymphocytes, Tumor-Infiltrating, CD8 Antigens, Treatment Outcome, CD8-Positive T-Lymphocytes, Disease-Free Survival, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.